🇺🇸 FDA
Patent

US 7491798

Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 7491798 (Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
46
CPC classes
A61K, A61K2039/505, A61K38/00